Vaccitech has announced that it has entered into a clinical partnership with Cancer Research UK to develop a novel immunotherapy as a treatment option for patients with non-small cell lung cancer.

Until January 15, 2020, researchers up to 35 years, with an advanced degree, who are working in Europe are invited to apply online for the Eppendorf Award for Young European Investigators 2020.

BioAscent scientists have helped to discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.

IONTAS has been informed that International Biotechnology Center (IBC) Generium has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B Cell Acute Lymphoblastic Leukemia (ALL).

Onconova and Inceptua Medicines Access have announced that they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

The global pharmaceutical company and service partner Inceptua and Bendalis have announced the signing of an exclusive clinical trial supply agreement for oncology generics.

BioCity has released the UK Life Science Start-Up Report, an in-depth analysis of emerging businesses within the life sciences across the UK.

ZEISS has introduced four new high-quality CMOS cameras for digital imaging in light microscopy.

Repositive has unveiled molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery.

A paper discussing recent preclinical advances of Bavarian Nordic’s novel cancer immunotherapy platform has been published in Nature Communications.